Skip to Main Content

Good morning. Elizabeth Cooney here in Boston, sitting in for Ed Silverman, who’s on holiday this week. I’ll be queuing up the coffee (French roast) and some news items to start the day.

The U.K. has signed agreements to buy 90 million doses of vaccines in development by drugmakers including Pfizer (PFE), BioNTech (BNTX), and Valneva (VLA), joining countries around the world racing to secure supplies of protection against Covid-19, Bloomberg tells us. Britain, a nation of 66 million people, has already struck a supply agreement for a vaccine being tested by AstraZeneca (AZN) with the University of Oxford. Shares in AstraZeneca rose as much as 5.2% to a record in London ahead of news from a clinical trial due later today.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!